End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
7,320
KRW
|
-0.41%
|
|
+3.54%
|
+8.93%
|
Mar. 27 |
Green Chemical Co., Ltd.'s Equity Buyback Plan Extended till March 27, 2025.
|
CI
| Mar. 21 |
Daishin Securities Co.,Ltd announced that it expects to receive KRW 49.9999294 billion in funding from KB Securities Co., Ltd., KDB Capital Corp., Brain Asset Management Co., Ltd., Green Chemical Co., Ltd., Shinhan Investment & Securities Co., Ltd. and other investors
|
CI
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
72,000
|
82,920
|
239,280
|
222,480
|
229,680
|
156,753
|
Enterprise Value (EV)
1 |
100,433
|
103,605
|
237,034
|
239,759
|
251,207
|
193,366
|
P/E ratio
|
28.2
x
|
14.6
x
|
22.6
x
|
13.6
x
|
77.8
x
|
46.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.28
x
|
0.36
x
|
0.99
x
|
0.78
x
|
0.71
x
|
0.56
x
|
EV / Revenue
|
0.4
x
|
0.45
x
|
0.98
x
|
0.84
x
|
0.77
x
|
0.68
x
|
EV / EBITDA
|
5.61
x
|
4.4
x
|
7.7
x
|
6.34
x
|
8.41
x
|
12.5
x
|
EV / FCF
|
14.1
x
|
7.58
x
|
8.01
x
|
43.4
x
|
67.7
x
|
-20.7
x
|
FCF Yield
|
7.09%
|
13.2%
|
12.5%
|
2.31%
|
1.48%
|
-4.84%
|
Price to Book
|
0.66
x
|
0.75
x
|
2.05
x
|
1.75
x
|
1.82
x
|
1.29
x
|
Nbr of stocks (in thousands)
|
24,082
|
24,000
|
24,000
|
24,000
|
24,000
|
23,326
|
Reference price
2 |
2,990
|
3,455
|
9,970
|
9,270
|
9,570
|
6,720
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
254,122
|
231,874
|
242,398
|
286,224
|
324,927
|
282,346
|
EBITDA
1 |
17,899
|
23,560
|
30,769
|
37,838
|
29,877
|
15,449
|
EBIT
1 |
3,365
|
7,811
|
14,708
|
20,827
|
17,220
|
4,952
|
Operating Margin
|
1.32%
|
3.37%
|
6.07%
|
7.28%
|
5.3%
|
1.75%
|
Earnings before Tax (EBT)
1 |
2,666
|
6,691
|
12,683
|
21,863
|
5,989
|
795.9
|
Net income
1 |
2,513
|
5,580
|
10,340
|
15,929
|
2,870
|
3,350
|
Net margin
|
0.99%
|
2.41%
|
4.27%
|
5.57%
|
0.88%
|
1.19%
|
EPS
2 |
106.0
|
236.5
|
441.9
|
682.9
|
123.1
|
144.0
|
Free Cash Flow
1 |
7,120
|
13,674
|
29,583
|
5,529
|
3,709
|
-9,355
|
FCF margin
|
2.8%
|
5.9%
|
12.2%
|
1.93%
|
1.14%
|
-3.31%
|
FCF Conversion (EBITDA)
|
39.78%
|
58.04%
|
96.14%
|
14.61%
|
12.42%
|
-
|
FCF Conversion (Net income)
|
283.33%
|
245.04%
|
286.1%
|
34.71%
|
129.23%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
28,433
|
20,685
|
-
|
17,279
|
21,527
|
36,613
|
Net Cash position
1 |
-
|
-
|
2,246
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.589
x
|
0.878
x
|
-
|
0.4566
x
|
0.7205
x
|
2.37
x
|
Free Cash Flow
1 |
7,120
|
13,674
|
29,583
|
5,529
|
3,709
|
-9,355
|
ROE (net income / shareholders' equity)
|
2.32%
|
5.17%
|
9.33%
|
13.5%
|
2.33%
|
2.76%
|
ROA (Net income/ Total Assets)
|
1.09%
|
2.6%
|
5.06%
|
6.7%
|
5.27%
|
1.56%
|
Assets
1 |
229,646
|
214,854
|
204,525
|
237,719
|
54,452
|
215,396
|
Book Value Per Share
2 |
4,544
|
4,597
|
4,855
|
5,290
|
5,251
|
5,217
|
Cash Flow per Share
2 |
213.0
|
353.0
|
1,115
|
841.0
|
504.0
|
291.0
|
Capex
1 |
6,321
|
6,048
|
3,385
|
8,920
|
14,411
|
29,016
|
Capex / Sales
|
2.49%
|
2.61%
|
1.4%
|
3.12%
|
4.44%
|
10.28%
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
|
1st Jan change
|
Capi.
|
---|
| +8.93% | 124M | | +5.14% | 103B | | -1.80% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|